Publications by authors named "Andrew Hiatt"

Claim this Profile
T
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.
Chad E Mire, Joan B Geisbert, Viktoriya Borisevich, Karla A Fenton, Krystle N Agans, Andrew Hiatt

Sci Transl Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation.
Alena V Savonenko, Tatiana Melnikova, Yuchuan Wang, Hayden Ravert, Yongjun Gao, Andrew Hiatt

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibody therapy for Junin virus infection.
Larry Zeitlin, Joan B Geisbert, Daniel J Deer, Karla A Fenton, Ognian Bohorov, Andrew Hiatt

Proc Natl Acad Sci U S A· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emergence of antibody therapies for Ebola.
Andrew Hiatt, Michael Pauly, Kevin Whaley, Xiangguo Qiu, Gary Kobinger

Hum Antibodies· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging antibody-based products.
Kevin J Whaley, Josh Morton, Steve Hume, Ernie Hiatt, Barry Bratcher, Andrew Hiatt

Curr Top Microbiol Immunol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.
Andrew Hiatt, Natasha Bohorova, Ognian Bohorov, Charles Goodman, Do Kim

Proc Natl Acad Sci U S A· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designed IgM from glycoengineering.
Andrew Hiatt

Proc Natl Acad Sci U S A· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant-Derived Monoclonal Antibodies for Prevention and Treatment of Infectious Disease.
Andrew Hiatt, Kevin J Whaley, Larry Zeitlin

Microbiol Spectr· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model.
Larry Zeitlin, Ognian Bohorov, Natasha Bohorova, Andrew Hiatt, Do H Kim

MAbs· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiantibody strategies for HIV.
Andrew Hiatt, Larry Zeitlin, Kevin J Whaley

Clin Dev Immunol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's therapeutics: translation of preclinical science to clinical drug development.
Alena V Savonenko, Tatiana Melnikova, Andrew Hiatt, Tong Li, Paul F Worley

Neuropsychopharmacology· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.
Larry Zeitlin, James Pettitt, Corinne Scully, Natasha Bohorova, Do Kim, Andrew Hiatt

Proc Natl Acad Sci U S A· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging antibody products and Nicotiana manufacturing.
Kevin J Whaley, Andrew Hiatt, Larry Zeitlin

Hum Vaccin· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies from plants: a new speed record.
Andrew Hiatt, Michael Pauly

Proc Natl Acad Sci U S A· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis